| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ... Nature 507 (7490), 109-113, 2014 | 673 | 2014 |
| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ... Nature 490 (7420), 412-416, 2012 | 627 | 2012 |
| Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells Y Gao, F Souza-Fonseca-Guimaraes, T Bald, SS Ng, A Young, SF Ngiow, ... Nature immunology 18 (9), 1004-1015, 2017 | 584 | 2017 |
| Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing N Gehrke, C Mertens, T Zillinger, J Wenzel, T Bald, S Zahn, T Tüting, ... Immunity 39 (3), 482-495, 2013 | 445 | 2013 |
| The experimental power of FR900359 to study Gq-regulated biological processes R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ... Nature communications 6 (1), 10156, 2015 | 371 | 2015 |
| The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies T Bald, MF Krummel, MJ Smyth, KC Barry Nature immunology 21 (8), 835-847, 2020 | 361 | 2020 |
| Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ... Cancer discovery 4 (6), 674-687, 2014 | 289 | 2014 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 251 | 2017 |
| Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, H Zhang, J Madore, ... Cancer discovery 9 (12), 1754-1773, 2019 | 221 | 2019 |
| Genome-wide in vivo screen identifies novel host regulators of metastatic colonization L van der Weyden, MJ Arends, AD Campbell, T Bald, H Wardle-Jones, ... Nature 541 (7636), 233-236, 2017 | 217 | 2017 |
| Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment K Nakamura, S Kassem, A Cleynen, ML Chretien, C Guillerey, EM Putz, ... Cancer cell 33 (4), 634-648. e5, 2018 | 200 | 2018 |
| MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment S Riesenberg, A Groetchen, R Siddaway, T Bald, J Reinhardt, D Smorra, ... Nature communications 6 (1), 8755, 2015 | 199 | 2015 |
| BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection RJ Mills, SJ Humphrey, PRJ Fortuna, M Lor, SR Foster, GA Quaife-Ryan, ... Cell 184 (8), 2167-2182. e22, 2021 | 161 | 2021 |
| MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy J Reinhardt, J Landsberg, JL Schmid-Burgk, BB Ramis, T Bald, N Glodde, ... Cancer research 77 (17), 4697-4709, 2017 | 161 | 2017 |
| The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation SS Ng, F De Labastida Rivera, J Yan, D Corvino, I Das, P Zhang, R Kuns, ... Nature immunology 21 (10), 1205-1218, 2020 | 143 | 2020 |
| Eomes-dependent loss of the co-activating receptor CD226 restrains CD8+ T cell anti-tumor functions and limits the efficacy of cancer immunotherapy M Weulersse, A Asrir, AC Pichler, L Lemaitre, M Braun, N Carrié, ... Immunity 53 (4), 824-839. e10, 2020 | 119 | 2020 |
| CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms XY Li, I Das, A Lepletier, V Addala, T Bald, K Stannard, D Barkauskas, ... The Journal of clinical investigation 128 (6), 2613-2625, 2018 | 116 | 2018 |
| CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ... Immunity 53 (4), 805-823. e15, 2020 | 110 | 2020 |
| Basophils promote tumor rejection via chemotaxis and infiltration of CD8+ T cells IM Sektioglu, R Carretero, N Bulbuc, T Bald, T Tüting, AY Rudensky, ... Cancer research 77 (2), 291-302, 2017 | 95 | 2017 |
| Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes R Reuten, TR Patel, M McDougall, N Rama, D Nikodemus, B Gibert, ... Nature communications 7 (1), 13515, 2016 | 95 | 2016 |
Thomas TütingDepartment of Dermatology, University Hospital Magdeburg, GermanyVerified email at med.ovgu.de
